Navigation Links
Catalent to Showcase Innovative Omega-3 Dose Forms and Lead Informative Sessions at SupplySide West

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is to participate in a half-day workshop, along with Euromonitor International, on the formulation of consumer health products, as part of SupplySide West, which runs from Sept. 25 – 29, 2017, at the Mandalay Bay Hotel and Resort, Las Vegas.

Titled “Supporting Healthy Aging with Targeted Formulations, Product Forms,” the workshop will take place Tuesday, Sept. 26, at 1:30 p.m. Key industry leaders contributing to the discussion will include Dr. Jeffrey E. Browne, Catalent’s Director of Science and Technology. The workshop will provide industry scientists and executives with information on aging trends, innovative formulation technologies and emerging solutions targeted to meet the specific needs of the aging consumer.

For more information on the workshop and to register, visit catalent/SupplySide West

Dr. Browne will also contribute to a Global Organization for EPA and DHA Omega-3 (GOED)-moderated panel discussion on the problems of product oxidation in the industry on Wednesday, Sept. 27 at 11.45 a.m. at the Omega-3 Resource Center Theater.

Catalent is the exclusive sponsor of the GOED Pavilion at the show, and will be showcasing its new high potency Omega–3 product, EasyBurst® chewable fish oil, throughout the event at booth N147. This innovative chewable product addresses several of the challenges associated with fish oil supplements, including large capsule size, odors and unpleasant aftertaste, offering consumers a smaller, chewable dosage form that does not require water.

Additionally, on Wednesday, Sept. 27 at 3:30 p.m., Timothy Doran, Vice President and General Manager of Nutritional Softgels, will present “Omega-3 Innovative Dosage Forms” at the GOED Pavilion, where he will discuss unique Omega-3 formulation considerations and innovative dosage forms.

For more information visit Catalent booth LL159 or go to catalent/SupplySide West. To arrange a meeting with any of the attending Catalent executives at the event, contact Richard Kerns at NEPR

About Catalent
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 10,000 people, including over 1,400 scientists, at more than 30 facilities across five continents, and in fiscal 2017 generated more than $2 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit

More products. Better treatments. Reliably supplied.™

Read the full story at

Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved

Related medicine news :

1. Catalent Invests $5.5 Million to Increase Clinical Storage Capacity at its Philadelphia Site
2. Catalent Signs Commercial Manufacturing Agreement with US WorldMeds for Lofexidine
3. Catalent Provides Commercial Manufacturing of Lexicon Pharmaceuticals' Orphan Drug XERMELO™ Following FDA Approval
4. Catalent to Launch Innovative Fish Oil Supplement Product at Vitafoods Europe
5. Challenges and Strategies to Automate Potency Assays to be Discussed by Catalent Expert at Upcoming CASSS Bioassays Symposium
6. Catalent Expands Kansas City Clinical Storage and Secondary Packaging Capabilities to Meet Growing Demand for Cold Chain Services
7. Catalent Wins Prestigious Clinical Supply Chain Excellence Award at BioPharma Asia Convention
8. Challenges and Innovation in Clinical Trial Supply to be Presented by Catalent Experts at Upcoming Conferences
9. Catalent to Host Workshop with Leading Biologics Experts on Advanced Protein Development and Delivery at Upcoming Drug Delivery Partnerships Conference
10. Innovative Strategies for the Development of Lipid-based Oral Medicines to be Presented by Catalent and Gattefossé at Forthcoming Workshop
11. Accelerated Biopharmaceutical Development through Strategic Analytical Partnerships to be Discussed by Catalent Expert at Upcoming WCBP Conference
Post Your Comments:
(Date:3/19/2020)... ... March 20, 2020 , ... With ICH E8(R1) set to be adopted ... than they do today. Be ready to implement the new guidelines. , The ... how to leverage the revised guidelines’ quality-by-design approaches, expanded study designs and data source ...
(Date:3/16/2020)... ... March 16, 2020 , ... To avoid the potential ... Services Authority is implementing several new universal health and safety measures agency-wide. ... staff," said Dr. Monteic A. Sizer, executive director of Northeast Delta. "Extensive discussion ...
(Date:3/15/2020)... ... March 13, 2020 , ... Special ... mission to bridge the gap by connecting individuals with autism and other developmental ... to attain fulfilling and independent lives has not wavered. , These past ...
(Date:3/15/2020)... ... March 14, 2020 , ... ... confusing information surrounding the Coronavirus (COVID-19) pandemic, National HouseCheck Corporation (‘HouseCheck’) is ... of businesses and employees. HouseCheck has launched its nationwide Virus Remediation and ...
(Date:3/13/2020)... ... March 13, 2020 , ... The Berman Law Group today announced ... China, Hubei Province, the City of Wuhan, and several Chinese government ministries, on behalf ... lawsuit was filed in the Southern District of Florida, and seeks billions of dollars ...
Breaking Medicine News(10 mins):
(Date:3/27/2020)... ... March 27, 2020 , ... PTS Diagnostics, a U.S.-based manufacturer ... as President and Chief Executive Officer. , Mr. Chapman brings 20 years of ... ARKRAY USA, Inc. He joins PTS Diagnostics with an accomplished track record regarding ...
(Date:3/20/2020)... ... March 20, 2020 , ... Despite the presence of the lone ... and the Gulf of Mexico are low, and it might be due to the ... time at the 2020 Annual Meeting of the American Academy of Allergy, Asthma & ...
(Date:3/20/2020)... , ... March 20, 2020 , ... New Alliance Academy ... and productive life, as well as encourages those interested in pursuing tertiary studies to ... is whether adolescents who attend the school have a good chance of progressing into ...
Breaking Medicine Technology: